Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 3.159
-0.001 (-0.03%)
Jan 23, 2026, 12:29 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 9.53 million as of January 23, 2026. Its market cap has decreased by -24.00% in one year.
Market Cap
9.53M
Enterprise Value
24.66M
Revenue
4.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.16
Market Cap Chart
Since September 17, 1997, Proteome Sciences's market cap has decreased from 27.59M to 9.53M, a decrease of -65.44%. That is a compound annual growth rate of -3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 9.53M | 29.20% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.30B |
| GSK plc | 72.40B |
| Haleon | 33.68B |
| Smith & Nephew | 10.50B |
| genedrive | 11.58M |
| Verici Dx | 10.97M |
| IXICO | 10.66M |
| Genflow Biosciences | 9.38M |